In a major shift, the US Food and Drug Administration is relaxing a long-standing drug approval requirement for common diseases.

Mpox vaccination significantly reduces disease severity compared with no vaccination, although protection may wane 2 years after the last dose.

Doxycycline PEP uptake after STI diagnosis varies by region and is most frequent among US male veterans on PrEP or living with HIV.

Adults consuming the highest amounts of ultraprocessed foods have an increased risk for cardiovascular disease.

US health officials are proposing a new way to develop and approve custom-made treatments for people with rare and hard-to-treat conditions.

The AAP 2026 schedule maintains status for vaccines the CDC moved to shared clinical decision-making, aiming to avoid clinician and parent confusion.

A considerable proportion of pregnant women are colonized with enterobacterales with ampicillin and ceftriaxone resistance in the US.

LA CAB for PrEP shows high effectiveness and persistence among Black cisgender and transgender women in the United States.

The FDA has approved Dupixent (dupilumab) for the treatment of adult and pediatric patients aged 6 years and older with allergic fungal rhinosinusitis.

Sepsis-associated encephalopathy affects about two-thirds of patients with sepsis and pulmonary infection and is linked to higher mortality.

Real-world data show an ibalizumab-based regimen provides sustained virologic suppression in heavily treatment-experienced ...

On Monday, the CDC announced that Ralph Abraham, its deputy secretary general, stepped down effective immediately after having been in the role for about 2 and a half months. HealthDay News — ...